From: Are radiologists ready to evaluate true response to immunotherapy?
Target lesions | irRC | irRECIST | iRECIST |
---|---|---|---|
Baseline: 30 × 19 mm | 30 × 19 = 570 | 30 | 30 |
First control: 15 × 13 mm | 15 × 13 = 195 PR (%65) | 15 PR (%50) | 15 UPD (new lesion) |
Second control: 15 × 13 mm, 59 × 54 mm, 29 × 21 mm and 20 × 10 mm | (15 × 13) + (59 × 54) + (29 × 21) + (20 × 10) PD (> %25) | 15 + 59 + 29 + 20 PD (> %20) | CPD (3 new lesion) |